Jeroen J M A Hendrikx (J J M A Hendrikx)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Clostridium Difficile

Room Temperature

Top Venues

EJNMMI radiopharmacy and chemistry

Pharmacology research & perspectives

Clinical cancer research : an official journal of the American Association for Cancer Research

Targeted oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Elke A van Brandwijk, Else A Aalbersberg, Arman S Hosseini, Alwin D R Huitema, Jeroen J M A Hendrikx
Automated radiolabelling of [ 68 Ga]Ga-PSMA-11 (gallium ( 68 Ga)-gozetotide) using the Locametz® kit and two generators. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Elke A van Brandwijk, Else A Aalbersberg, Arman S Hosseini, Alwin D R Huitema, Jeroen J M A Hendrikx
Automated radiolabelling of [ 68 Ga]Ga-PSMA-11 (gallium ( 68 Ga)-gozetotide) using the Locametz® kit and two generators. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
T T Cao, E A Aalbersberg, M M Geluk-Jonker, Jeroen J M A Hendrikx
Validation of an automated dispensing system for subsequent dose dispensing of different radionuclides. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Elke A van Brandwijk, Else A Aalbersberg, Arman S Hosseini, Alwin D R Huitema, Jeroen J M A Hendrikx
Automated radiolabelling of [ 68 Ga]Ga-PSMA-11 (gallium ( 68 Ga)-gozetotide) using the Locametz® kit and two generators. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
T T Cao, E A Aalbersberg, M M Geluk-Jonker, Jeroen J M A Hendrikx
Validation of an automated dispensing system for subsequent dose dispensing of different radionuclides. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
T T Cao, E A Aalbersberg, M M Geluk-Jonker, Jeroen J M A Hendrikx
Validation of an automated dispensing system for subsequent dose dispensing of different radionuclides. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Dirk Jan A R Moes, Jeroen J M A Hendrikx, Henk-Jan Guchelaar, Ron H J Mathijssen, J L Bakker, Vincent O Dezentjé, Nikki de Rouw, Nielka P van Erp, Egbert F Smit, Michel van den Heuvel, Thijs H Oude Munnink, Maartje van Kats, Sander Croes, Judith R Kroep, Juliette Zwaveling, Rob Ter Heine
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan. Targeted oncology (2024)
Elke A van Brandwijk, Else A Aalbersberg, Arman S Hosseini, Alwin D R Huitema, Jeroen J M A Hendrikx
Automated radiolabelling of [ 68 Ga]Ga-PSMA-11 (gallium ( 68 Ga)-gozetotide) using the Locametz® kit and two generators. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Étienne Chatelut, Jeroen J M A Hendrikx, Jennifer H Martin, Joseph Ciccolini, Dirk Jan A R Moes
Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology. Pharmacology research & perspectives 9 (2) (2021)
Jeroen J M A Hendrikx, Frederik E Stuurman, Ji-Ying Song, Vincent A de Weger, Jurjen S Lagas, Hilde Rosing, Jos H Beijnen, Alfred H Schinkel, Jan H M Schellens, Serena Marchetti
No relation between docetaxel administration route and high-grade diarrhea incidence. Pharmacology research & perspectives 8 (4) (2021)
Jeroen J M A Hendrikx, Jos H Beijnen, Alwin D R Huitema
Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter]. Clinical pharmacology : advances and applications 12 (2020)
Vincent A de Weger, Frederik E Stuurman, Stijn L W Koolen, Johannes J Moes, Jeroen J M A Hendrikx, Emilia Sawicki, Bas Thijssen, Marianne Keessen, Hilde Rosing, Marja Mergui-Roelvink, Alwin D R Huitema, Bastiaan Nuijen, Jos H Beijnen, Jan H M Schellens, Serena Marchetti
A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (18) (2019)